Cargando…
Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe
AIMS: To analyse the treatment and control of dyslipidaemia in patients at high and very high cardiovascular risk being treated for the primary prevention of cardiovascular disease (CVD) in Europe. METHODS AND RESULTS: Data were assessed from the European Study on Cardiovascular Risk Prevention and...
Autores principales: | Halcox, Julian P., Tubach, Florence, Lopez-Garcia, Esther, De Backer, Guy, Borghi, Claudio, Dallongeville, Jean, Guallar, Eliseo, Medina, Jesús, Perk, Joep, Sazova, Ogün, Sweet, Stephen, Roy, Carine, Banegas, José R., Rodriguez-Artalejo, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333116/ https://www.ncbi.nlm.nih.gov/pubmed/25692692 http://dx.doi.org/10.1371/journal.pone.0115270 |
Ejemplares similares
-
C-reactive protein levels in patients at cardiovascular risk: EURIKA study
por: Halcox, Julian PJ, et al.
Publicado: (2014) -
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
por: Banegas, José R., et al.
Publicado: (2011) -
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
por: Halcox, Julian P., et al.
Publicado: (2017) -
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study
por: Guallar, Eliseo, et al.
Publicado: (2011) -
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)
por: Rodríguez-Artalejo, Fernando, et al.
Publicado: (2010)